Bridger Management’s Wave Life Sciences WVE Stock Holding History

Bridger Management’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-653,141	Closed	-$17M	–	34
2019 Q2	$17M	Buy	653,141 +256,051	+64%	+$7.18M	1.34%	27
2019 Q1	$15.4M	Buy	397,090 +85,697	+28%	+$3.48M	1.22%	27
2018 Q4	$13.1M	Sell	311,393 -104,582	-25%	-$4.65M	1.09%	33
2018 Q3	$20.8M	Sell	415,975 -146,640	-26%	-$6.62M	1.2%	30
2018 Q2	$21.5M	Buy	562,615 +43,180	+8%	+$1.86M	1.17%	33
2018 Q1	$20.8M	Buy	519,435 +181,486	+54%	+$7.63M	1.26%	29
2017 Q4	$11.9M	Buy	337,949 +47,064	+16%	+$1.37M	0.78%	30
2017 Q3	$6.33M	Buy	+290,885	New	+$5.85M	0.38%	34

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bridger Management's WVE Position: Q3 2019 in Review

Bridger Management sold out of Wave Life Sciences (WVE) in Q3 2019, closing a stake of 653,141 shares — an estimated $17M sold.

Bridger Management first reported a position in WVE in Q3 2017 and held it in 8 quarters. The position peaked at $21.5M in Q2 2018. 88 funds tracked by Wall St. Rank hold WVE as of Q3 2019.

Bridger Management reported no remaining Wave Life Sciences position as of Q3 2019 after selling out during the quarter.
Bridger Management sold 653,141 Wave Life Sciences shares in Q3 2019, an estimated $17M.
Bridger Management first reported a position in Wave Life Sciences in Q3 2017 and held it in 8 quarters.
Bridger Management's Wave Life Sciences position peaked at $21.5M in Q2 2018.
88 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2019.

Based on Bridger Management's 13F filing for Q3 2019, filed 14 Nov 2019.